Scholarlink

<p>Population aging is a global demographic inevitability, driven by advancements in healthcare, increased life expectancy, and declining fertility rates. Growing evidence implicates gut microbiota dysbiosis in the pathogenesis of cognitive impairments and neurodegenerative disorders commonly associated with aging, primarily through disruptions in immune, metabolic, and neuroendocrine signaling along the gut–brain axis. This review synthesizes current literature on the therapeutic potential of probiotic bacteria, such as <i>Lactobacillus</i> and <i>Bifidobacterium</i>, to enhance glial function, maintain blood-brain barrier integrity, and neurocognitive performance in older adults. However, probiotic efficacy is highly strain-specific and context-dependent, necessitating individualized evaluation of each microbial strain’s therapeutic profile. Future research should prioritize precision microbiome-based strategies to elucidate mechanisms of action, optimal strain combinations, and their effectiveness across varying degrees of cognitive decline in the aging population. Furthermore, diet, physical activity, and microbial exposures represent essential, non-pharmacological tools for maintaining microbiota eubiosis and supporting neurocognitive health in aging populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Paradigm Shift of Microbiota-gut-brain Axis During Aging: Potential Role of Probiotics to Improve Cognitive Decline

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月4日

查看全文
  • Sneha Dutta,
  • Tapas K. Dutta,
  • Pramod K. Nanda,
  • Pubali Dhar,
  • Arun K. Das,
  • Arun K. Bhunia

摘要

Population aging is a global demographic inevitability, driven by advancements in healthcare, increased life expectancy, and declining fertility rates. Growing evidence implicates gut microbiota dysbiosis in the pathogenesis of cognitive impairments and neurodegenerative disorders commonly associated with aging, primarily through disruptions in immune, metabolic, and neuroendocrine signaling along the gut–brain axis. This review synthesizes current literature on the therapeutic potential of probiotic bacteria, such as Lactobacillus and Bifidobacterium, to enhance glial function, maintain blood-brain barrier integrity, and neurocognitive performance in older adults. However, probiotic efficacy is highly strain-specific and context-dependent, necessitating individualized evaluation of each microbial strain’s therapeutic profile. Future research should prioritize precision microbiome-based strategies to elucidate mechanisms of action, optimal strain combinations, and their effectiveness across varying degrees of cognitive decline in the aging population. Furthermore, diet, physical activity, and microbial exposures represent essential, non-pharmacological tools for maintaining microbiota eubiosis and supporting neurocognitive health in aging populations.